Bottom line
Is RSYEX a good fund? The bottom line
RSYEX is the Class Y share class of Victory RS Small Cap Growth Fund, a managed small-cap mutual fund from Victory Capital.
Its expense ratio is 1.13% — about $113 a year on every $10,000 invested, more expensive than 63% of small-cap funds we track.
It returned +1.2% over one year, −5.3% a year over five years, +6.3% a year over ten (as of Dec 31, 2025, per its prospectus).
With $408 million in net assets and 106 holdings, its largest position is Mercury Systems, Inc. (2.9%) and the top 10 make up 20.4% of the portfolio.
What stands out
- No front-end sales load
What to watch
- 5-year return in the bottom quarter of its category
Updated Nov 19, 2026
What RSYEX invests in
The Victory RS Small Cap Growth Fund (the Fund) seeks to provide long-term capital growth.
The Adviser pursues the Funds investment objective by investing, under normal circumstances, at least 80% of its assets in small-capitalization companies. The Fund typically invests in equity securities of U.S. companies but may also invest any portion of its assets in foreign securities, including depositary receipts such as American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs). The Adviser currently considers a company to be a small-capitalization company if its market capitalization (at the time of purchase) is less than $3 billion or 120% of the market capitalization of the largest company included in the Russell 2000 Index (the Index) (currently, approximately $41.0 billion, based on the size of the largest company in the Index on March 31, 2026), whichever is greater. The size of companies in the Index changes with market conditions and the composition of the…
From the fund's prospectus (filed Jun 17, 2026).
RSYEX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| RSYEX | +1.2% | −5.3% | +6.3% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What RSYEX costs
On a $10,000 investment, RSYEX's 1.13% expense ratio costs about $113 a year. The prospectus estimates $1,406 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
RSYEX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Mercury Systems, Inc. | 2.87% |
| 2 | Esco Technologies Inc. | 2.11% |
| 3 | Msc Industrial Direct Co., Inc. | 2.07% |
| 4 | Semtech Corporation | 2.06% |
| 5 | Guardant Health, Inc. | 1.98% |
| 6 | Firstcash Holdings, Inc. | 1.98% |
| 7 | Revolution Medicines, Inc. | 1.93% |
| 8 | Riot Platforms, Inc. | 1.90% |
| 9 | Spyre Therapeutics Inc | 1.87% |
| 10 | Krystal Biotech Inc | 1.61% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 20.4% of the fund. See all top 25 holdings and asset mix →